- Report
- January 2026
- 192 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- November 2025
- 183 Pages
Global
From €4018EUR$4,500USD£3,492GBP
- Drug Pipelines
- July 2025
- 280 Pages
Global
From €2679EUR$3,000USD£2,328GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1786EUR$2,000USD£1,552GBP
- Report
- October 2025
- 163 Pages
Global
From €3500EUR$4,199USD£3,148GBP
- Report
- January 2026
- 180 Pages
Global
From €3165EUR$3,545USD£2,751GBP
€3517EUR$3,939USD£3,056GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Report
- February 2026
- 250 Pages
Global
From €4009EUR$4,490USD£3,484GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1786EUR$2,000USD£1,552GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1786EUR$2,000USD£1,552GBP
- Report
- March 2026
- 500 Pages
Global
From €4460EUR$4,995USD£3,876GBP
- Report
- March 2026
- 281 Pages
Global
From €6246EUR$6,995USD£5,428GBP
- Report
- May 2025
- 472 Pages
Global
From €6246EUR$6,995USD£5,428GBP
- Report
- March 2026
- 262 Pages
Global
From €6246EUR$6,995USD£5,428GBP
- Report
- March 2026
- 388 Pages
Global
From €6246EUR$6,995USD£5,428GBP
- Report
- December 2025
- 391 Pages
Global
From €4285EUR$4,799USD£3,724GBP
- Report
- October 2025
- 598 Pages
Global
From €4285EUR$4,799USD£3,724GBP
- Report
- February 2026
- 656 Pages
Global
From €4285EUR$4,799USD£3,724GBP
- Report
- December 2025
- 343 Pages
Global
From €4285EUR$4,799USD£3,724GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more